125 related articles for article (PubMed ID: 28754951)
1. Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency.
Silva LM; Stoll T; Kryza T; Stephens CR; Hastie ML; Irving-Rodgers HF; Dong Y; Gorman JJ; Clements JA
Sci Rep; 2017 Jul; 7(1):6789. PubMed ID: 28754951
[TBL] [Abstract][Full Text] [Related]
2. Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome.
Silva LM; Kryza T; Stoll T; Hoogland C; Dong Y; Stephens CR; Hastie ML; Magdolen V; Kleifeld O; Gorman JJ; Clements JA
Mol Cell Proteomics; 2019 May; 18(5):818-836. PubMed ID: 30705123
[TBL] [Abstract][Full Text] [Related]
3. Specificity studies on Kallikrein-related peptidase 7 (KLK7) and effects of osmolytes and glycosaminoglycans on its peptidase activity.
Oliveira JR; Bertolin TC; Andrade D; Oliveira LC; Kondo MY; Santos JA; Blaber M; Juliano L; Severino B; Caliendo G; Santagada V; Juliano MA
Biochim Biophys Acta; 2015 Jan; 1854(1):73-83. PubMed ID: 25448018
[TBL] [Abstract][Full Text] [Related]
4. Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics.
Yu Y; Prassas I; Dimitromanolakis A; Diamandis EP
J Biol Chem; 2015 Jul; 290(29):17762-17775. PubMed ID: 26032414
[TBL] [Abstract][Full Text] [Related]
5. Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses.
Eckhard U; Huesgen PF; Schilling O; Bellac CL; Butler GS; Cox JH; Dufour A; Goebeler V; Kappelhoff R; Keller UAD; Klein T; Lange PF; Marino G; Morrison CJ; Prudova A; Rodriguez D; Starr AE; Wang Y; Overall CM
Matrix Biol; 2016 Jan; 49():37-60. PubMed ID: 26407638
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analyses reveal an acidic prime side specificity for the astacin metalloprotease family reflected by physiological substrates.
Becker-Pauly C; Barré O; Schilling O; Auf dem Keller U; Ohler A; Broder C; Schütte A; Kappelhoff R; Stöcker W; Overall CM
Mol Cell Proteomics; 2011 Sep; 10(9):M111.009233. PubMed ID: 21693781
[TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of protease cleavage sites characterizes prime and non-prime specificity of cysteine cathepsins B, L, and S.
Biniossek ML; Nägler DK; Becker-Pauly C; Schilling O
J Proteome Res; 2011 Dec; 10(12):5363-73. PubMed ID: 21967108
[TBL] [Abstract][Full Text] [Related]
8. Protease specificity profiling by tandem mass spectrometry using proteome-derived peptide libraries.
Schilling O; auf dem Keller U; Overall CM
Methods Mol Biol; 2011; 753():257-72. PubMed ID: 21604128
[TBL] [Abstract][Full Text] [Related]
9. Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors.
de Veer SJ; Swedberg JE; Brattsand M; Clements JA; Harris JM
Biol Chem; 2016 Dec; 397(12):1237-1249. PubMed ID: 26894578
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein-related peptidase-7 regulates caspase-14 maturation during keratinocyte terminal differentiation by generating an intermediate form.
Yamamoto M; Miyai M; Matsumoto Y; Tsuboi R; Hibino T
J Biol Chem; 2012 Sep; 287(39):32825-34. PubMed ID: 22825846
[TBL] [Abstract][Full Text] [Related]
11. Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7.
Debela M; Beaufort N; Magdolen V; Schechter NM; Craik CS; Schmitt M; Bode W; Goettig P
Biol Chem; 2008 Jun; 389(6):623-32. PubMed ID: 18627343
[TBL] [Abstract][Full Text] [Related]
12. Structural Studies on the Inhibitory Binding Mode of Aromatic Coumarinic Esters to Human Kallikrein-Related Peptidase 7.
Hanke S; Tindall CA; Pippel J; Ulbricht D; Pirotte B; Reboud-Ravaux M; Heiker JT; Sträter N
J Med Chem; 2020 Jun; 63(11):5723-5733. PubMed ID: 32374603
[TBL] [Abstract][Full Text] [Related]
13. Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7.
Arama DP; Soualmia F; Lisowski V; Longevial JF; Bosc E; Maillard LT; Martinez J; Masurier N; El Amri C
Eur J Med Chem; 2015 Mar; 93():202-13. PubMed ID: 25682203
[TBL] [Abstract][Full Text] [Related]
14. Cleavage specificity analysis of six type II transmembrane serine proteases (TTSPs) using PICS with proteome-derived peptide libraries.
Barré O; Dufour A; Eckhard U; Kappelhoff R; Béliveau F; Leduc R; Overall CM
PLoS One; 2014; 9(9):e105984. PubMed ID: 25211023
[TBL] [Abstract][Full Text] [Related]
15. Factor Xa subsite mapping by proteome-derived peptide libraries improved using WebPICS, a resource for proteomic identification of cleavage sites.
Schilling O; auf dem Keller U; Overall CM
Biol Chem; 2011 Nov; 392(11):1031-7. PubMed ID: 21846260
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the prime and non-prime active site specificities of proteases by proteome-derived peptide libraries and tandem mass spectrometry.
Schilling O; Huesgen PF; Barré O; Auf dem Keller U; Overall CM
Nat Protoc; 2011 Jan; 6(1):111-20. PubMed ID: 21212787
[TBL] [Abstract][Full Text] [Related]
18. Non-combinatorial library screening reveals subsite cooperativity and identifies new high-efficiency substrates for kallikrein-related peptidase 14.
de Veer SJ; Swedberg JE; Parker EA; Harris JM
Biol Chem; 2012 Apr; 393(5):331-41. PubMed ID: 22505516
[TBL] [Abstract][Full Text] [Related]
19. Quantitative protease cleavage site profiling using tandem-mass-tag labeling and LC-MALDI-TOF/TOF MS/MS analysis.
Jakoby T; van den Berg BH; Tholey A
J Proteome Res; 2012 Mar; 11(3):1812-20. PubMed ID: 22250702
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.
Delaunay T; Deschamps L; Haddada M; Walker F; Soosaipillai A; Soualmia F; El Amri C; Diamandis EP; Brattsand M; Magdolen V; Darmoul D
Mol Oncol; 2017 Oct; 11(10):1330-1347. PubMed ID: 28636767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
